Tutorial
Robinhood Chain
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Tutorial
Profile · INSIDER
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Tutorial
Data sources
SEC Form 4
3h ago
House PTR
3h ago
SEC 13F
3h ago
Robinhood Chain
3h ago
Public company
Beam Therapeutics Inc.
BEAM
CIK 0001745999
EDGAR filings
Open in network
○
Watch BEAM
Price
$26.41
1 year
+14.5%
Disclosed transactions
1
Buys / sells
0 / 1
Max Insider Score
26
Connections with evidence
4
Customize layout
BEAM · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
26
ARK Investment Management LLC
13F filer
BEAM
Beam Therapeutics Inc.
TRIM
SELL
$65.16M
1.90M sh
Not disclosed
Verified connections
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
← Lobbied for
evidence
GRIDIRON PUBLIC AFFAIRS, LLC
LDA RR 2026 second quarter · Health issues · Aug 26, 2026
← Lobbied for
evidence
AVIVA STRATEGIES (FKA MGB CONSULTING)
LDA 2TY 2026 second quarter · issues not listed · Aug 26, 2026
← Holds
evidence
ARK Investment Management LLC
2.3% of reported portfolio · Aug 14, 2026
Aug 14, 2026
quarterly
SEC 13F
Evidence
Evidence
Close
Lobbying
$10K reported · de-duplicated
2026 Q2
$10K
via firms
2026 Q1
$0
via firms
AVIVA STRATEGIES (FKA MGB CONSULTING)
—
2026 Q1 · posted Aug 26, 2026 ·
AVIVA STRATEGIES (FKA MGB CONSULTING)
—
2026 Q2 · posted Aug 26, 2026 ·
GRIDIRON PUBLIC AFFAIRS, LLC
$10K
2026 Q2 · posted Aug 26, 2026 · Health issues
GRIDIRON PUBLIC AFFAIRS, LLC
—
2026 Q2 · posted Aug 26, 2026 · Health issues
Connected PAC contributions
FEC · direct to members
No contributions from a PAC connected to this company.
Disclosed trades
TradingView